Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia

BACKGROUND: The relevance of recurrent molecular abnormalities in cytogenetically normal (CN) acute myeloid leukemia (AML) was recently acknowledged by the inclusion of molecular markers such as NPM1, FLT3, and CEBPA as a complement to cytogenetic information within both the World Health Organizatio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Yang, Wen-Chi, Tsai, Wan-Chi, Lin, Pai-Mei, Yang, Ming-Yu, Liu, Yi-Chang, Chang, Chao-Sung, Yu, Wen-Hui, Lin, Sheng-Fung
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3844465/
https://ncbi.nlm.nih.gov/pubmed/23941109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1423-0127-20-58
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia